E6 Proteins from Diverse Papillomaviruses Self-Associate Both In Vitro and In Vivo

Journal of Molecular Biology

Volumn 396, Issue 1, 2010, Pages 90-104

  Zanier, Katia ^a   Ruhlmann, Christine ^b   Melin, Frederic ^a   Masson, Murielle ^a   Ould M'hamed Ould Sidi, Abdellahi ^a   Bernard, Xavier ^a   Fischer, Benoit ^c   Brino, Laurent ^c   Ristriani, Tutik ^a   Rybin, Vladimir ^d   Baltzinger, Mireille ^a   Vande Pol, Scott ^e   Hellwig, Petra ^a   Schultz, Patrick ^b   Travé, Gilles ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c Groupe Pierre Oudet   (France)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

cervical cancer; E6; HPV; ordered aggregation; self association

Indexed keywords

PROTEIN E6;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; BIOPHYSICS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GEL FILTRATION; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; OLIGOMERIZATION; PAPILLOMA VIRUS; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN SECONDARY STRUCTURE; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION; VIRUS STRAIN;

BOVINE PAPILLOMAVIRUS; EUKARYOTA; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 74649086278     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.11.022     Document Type: Article

References (38)

1. zur Hausen H. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111 (1999) 581-587
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87 (1995) 796-802
3. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 31 (2003) 52-56
4. Lambert P.F., Baker C.C., and Howley P.M. The genetics of bovine papillomavirus type 1. Annu. Rev. Genet. 22 (1988) 235-258
5. Narisawa-Saito M., and Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 98 (2007) 1505-1511
6. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 (1993) 495-505
7. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
8. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., and Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA 94 (1997) 11612-11616
9. Glaunsinger B., Lee S., Thomas M., Banks L., and Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19 (2000) 5270-5280
10. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., and Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21 (2002) 5088-5096
11. Jackson S., Harwood C., Thomas M., Banks L., and Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14 (2000) 3065-3073
12. Tong X., and Howley P.M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl Acad. Sci. USA 94 (1997) 4412-4417
13. Tong X., Boll W., Kirchhausen T., and Howley P.M. Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J. Virol. 72 (1998) 476-482
14. Nominé Y., Charbonnier S., Ristriani T., Stier G., Masson M., Cavusoglu N., et al. Domain substructure of HPV E6 protein: biophysical characterization of E6 C-terminal DNA-binding domain. Biochemistry 42 (2003) 4909-4917
15. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., et al. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol. Cell 21 (2006) 665-678
16. Nominé Y., Ristriani T., Laurent C., Lefèvre J.F., Weiss E., and Travé G. Formation of soluble inclusion bodies by HPV E6 oncoprotein fused to maltose-binding protein. Protein Expr. Purif. 23 (2001) 22-32
17. Degenkolbe R., Gilligan P., Gupta S., and Bernard H.U. Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein. Biochemistry 42 (2003) 3868-3873
18. Daniels P.R., Sanders C.M., Coulson P., and Maitland N.J. Molecular analysis of the interaction between HPV type 16 E6 and human E6-associated protein. FEBS Lett. 416 (1997) 6-10
19. Zanier K., Nomine Y., Charbonnier S., Ruhlmann C., Schultz P., Schweizer J., and Travé G. Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species. Protein Expr. Purif. 51 (2007) 59-70
20. Garcia-Alai M.M., Dantur K.I., Smal C., Pietrasanta L., and de Prat-Gay G. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines. Biochemistry 46 (2007) 341-349
21. Bohl J., Das K., Dasgupta B., and Vande Pol S.B. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. Virology 271 (2000) 163-170
22. Zanier K., Charbonnier S., Baltzinger M., Nomine Y., Altschuh D., and Travé G. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J. Mol. Biol. 349 (2005) 401-412
23. Nilsson M.R. Techniques to study amyloid fibril formation in vitro. Methods 34 (2004) 151-160
24. 2-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40 (2001) 1196-1204
25. Sibler A.P., Nordhammer A., Masson M., Martineau P., Travé G., and Weiss E. Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. Exp. Cell Res. 286 (2003) 276-287
26. Liu Y., Cherry J.J., Dineen J.V., Androphy E.J., and Baleja J.D. Determinants of stability for the E6 protein of papillomavirus type 16. J. Mol. Biol. 386 (2009) 1123-1137
27. Medcalf E.A., and Milner J. Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620 p53 conformation. Oncogene 8 (1993) 2847-2851
28. Liu Y., and Baleja J.D. Structure and function of the papillomavirus E6 protein and its interacting proteins. Front. Biosci. 13 (2008) 121-134
29. Tungteakkhun S.S., and Duerksen-Hughes P.J. Cellular binding partners of the human papillomavirus E6 protein. Arch. Virol. 153 (2008) 397-408
30. Chen J.J., Hong Y., Rustamzadeh E., Baleja J.D., and Androphy E.J. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273 (1998) 13537-13544
31. Thomas M., Dasgupta J., Zhang Y., Chen X., and Banks L. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology 376 (2008) 371-378
32. Nominé Y., Ristriani T., Laurent C., Lefèvre J.F., Weiss E., and Travé G. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng. 14 (2001) 297-305
33. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78 (2000) 1606-1619
34. Laue T., Shah B., Ridgeway T., and Pelletier S. Computer-aided interpretation of sedimentation data for proteins. In: Harding S.E., and Rowe A.J. (Eds). Analytical Ultracentrifugation in Biochemistry and Polymer Science (1992), Royal Society for Chemistry, Cambridge, UK 90-125
35. Ristriani T., Nomine Y., Laurent C., Weiss E., and Travé G. Protein mutagenesis with monodispersity-based quality probing: selective inactivation of p53 degradation and DNA-binding properties of HPV E6 oncoprotein. Protein Expr. Purif. 26 (2002) 357-367
36. Xiao J.H., Davidson I., Matthes H., Garnier J.M., and Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65 (1991) 551-568
37. Pim D., Massimi P., and Banks L. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15 (1997) 257-264
38. Barth A. Infrared spectroscopy of proteins. Biochim. Biophys. Acta 1767 (2007) 1073-1101